A phase 3 clinical trial of duloxetine in patients with osteoarthritis
Phase 3
- Conditions
- osteoarthritis
- Registration Number
- JPRN-jRCT2080222625
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Participants meet the ACR criteria for idiopathic osteoarthritis of the knee.
And et al.
Exclusion Criteria
Participants with past history of multiple episodes of drug allergy.
Participants previously treated with duloxetine.
And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method